Self-administered MDMA produces dose- and time-dependent serotonin deficits in the rat brain

Addiction Biology

Volumn 18, Issue 3, 2013, Pages 441-447

  Do, Jennifer ^a   Schenk, Susan ^a  

^a VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

Author keywords

Addiction; amphetamines; MDMA; neuroadaptation; self administration; serotonin

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; SEROTONIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOSE TIME EFFECT RELATION; DRUG SELF ADMINISTRATION; EXPOSURE; FRONTAL CORTEX; HIPPOCAMPUS; MALE; NEUROCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN BRAIN LEVEL;

ADAPTATION, PHYSIOLOGICAL; ANALYSIS OF VARIANCE; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; INFUSIONS, INTRAVENOUS; MALE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; RATS; RATS, SPRAGUE-DAWLEY; SELF ADMINISTRATION; SEROTONIN; SEROTONIN AGENTS;

EID: 84876103868     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00370.x     Document Type: Article

References (30)

1. Andõ RD, Ádori C, Kirilly E, Molnár E, Kovács GG, Ferrington L, Kelly PAT, Bagdy G, (2010) Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion. Behav Brain Res 207: 280-289.
2. Banks ML, Czoty PW, Gage HD, Bounds MC, Garg PK, Garg S, Nader MA, (2008) Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys. Neuropsychopharmacology 33: 219-225.
3. Battaglia G, Yeh SY, De Souza EB, (1988) MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons. Pharmacol Biochem Behav 29: 269-274.
4. Battaglia G, Yeh SY, O'Hearn E, Molliver ME, Kuhar MJ, De Souza EB, (1987) 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites. J Pharmacol Exp Ther 242: 911-916.
5. Baumann MH, Wang X, Rothman RB, (2007) 3, 4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings. Psychopharmacology 189: 407-424.
6. Bhide NS, Lipton J, Cunninghamn J, Yamamoto BK, Gudelsky GA, (2009) Repeated exposure to MDMA provides neuroprotection against subsequent MDMA-induced serotonin depletion in brain. Brain Res 1286: 32-41.
7. Buchert R, Thomasius R, Nebeling B, Petersen K, Obrocki J, Jenicke L, Wilke F, Wartberg L, Zapletalova P, Clausen M, (2003) Long-term effects of "ecstasy" use on serotonin transporter of the brain investigated by PET. J Nucl Med 44: 375-384.
8. Commins DL, Vosmer GL, Virus RM, Woolverton WL, Schuster CR, Seiden LS, (1987) Biochemical and histological evidence that methylenedioxymethamphetamine (MDMA) is toxic to neurons in the rat brain. J Pharmacol Exp Ther 241: 338-345.
9. De la Garza R, Fabrizio KR, Gupta A, (2007) Relevance of rodent models of intravenous MDMA self-administration to human MDMA consumption patterns. Psychopharmacology 189: 425-434.
10. Degenhardt L, Bruno R, Topp L, (2010) Is ecstasy a drug of dependence? Drug Alcohol Depend 107: 1-10.
11. Fantegrossi WE, (2007) Reinforcing effects of methylenedioxy amphetamine congeners in rhesus monkeys: are intravenous self-administration experiments relevant to MDMA neurotoxicity? Psychopharmacology 189: 471-482.
12. Fantegrossi WE, Woolverton WL, Kilbourne M, Sherman P, Yuan J, Hatzidimitriou G, Ricaurte GA, Woods JH, Winger G, (2004) Behavioural and neural consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys. Neuropsychopharmacology 29: 1270-1281.
13. Fischer C, Hatzidimitriou G, Wlos J, Katz J, Ricaurte G, (1995) Reorganization of ascending 5-HT axon projections in animals previously exposed to recreational drug (±) 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'). J Neurosci 15: 5476-5485.
14. Heffner TG, Hartman JA, Seiden LS, (1980) A rapid method for the regional dissection of the rat brain. Pharmacol Biochem Behav 13: 453-456.
15. Lieb R, Schuetz CG, Pfister H, Sydow K, Wittchen U, (2002) Mental disorders in ecstasy users: a prospective-longitudinal investigation. Drug Alcohol Depend 68: 195-207.
16. McCann UD, Szabo Z, Scheffel U, Dannals RF, Ricaurte GA, (1998) Positron emission tomographic evidence of toxic effects of MDMA("Ecstasy") on brain serotonin neurons in human beings. Lancet 352: 1433-1437.
17. MacInnes N, Handley SL, Harding GFA, (2001) Former chronic methylenedioxymethamphetamine (MDMA or ecstasy) users report mild depressive symptoms. J Psychopharmacol 15: 181-186.
18. O'Shea E, Granados R, Esteban B, Colado MI, Green AR, (1998) The relationship between the degree of neurodegeneration of rat brain 5-HT nerve terminals and the dose and frequency of administration of MDMA ('ecstasy'). Neuropharmacology 37: 919-926.
19. Parrott AC, (2001) Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research. Hum Psychopharmacol Clin Exp 16: 557-577.
20. Piper BJ, Ali SY, Daniels LG, Meyer JS, (2010) Repeated intermittent methylenedioxymethamphetamine exposure protects against the behavioural and neurotoxic, but not hyperthermic, effects of an MDMA binge in adult rats. Synapse 64: 421-431.
21. Reneman L, Booij J, Schmand B. Brink W, Gunning B, (2000) Memory disturbances in 'ecstasy' users are correlated with an altered brain serotonin neurotransmission. Psychopharmacology 148: 322-324.
22. Reveron ME, Maier EY, Duvauchelle CL, (2010) Behavioral, thermal and neurochemical effects of acute and chronic 3, 4-methylenedioxymethamphetamine ('ecstasy') self-administration. Behav Brain Res 207: 500-507.
23. Sabol KE, Lew R, Richards JB, Vosmer GL, Seiden LS, (1996) Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part 1: synaptosomal uptake and tissue concentrations. J Pharmacol Exp Ther 276: 846-854.
24. Scanzello CR, Hatzidimitriou G, Martello AL, Katz JL, Ricaurte GA, (1993) Serotonergic recovery after (±) 3,4 (methylenedioxy) methamphetamine injury: observations in rats. J Pharmacol Exp Ther 264: 1484-1491.
25. Schenk S, (2009) MDMA self-administration in laboratory animals: a summary of literature and proposal for future research. Neuropsychobiology 60: 130-136.
26. Schenk S, Gittings D, Colussi-Mas J, (2011) Dopaminergic mechanisms of reinstatement of MDMA-seeking behaviour in rats. Br J Pharmacol 162: 1770-1780.
27. Schenk S, Gittings D, Johnston M, Daniela E, (2003) Development, maintenance and temporal pattern of self-administration maintained by ecstasy (MDMA) in rats. Psychopharmacology 169: 21-27.
28. Schenk S, Hely L, Lake B, Daniela E, Gittings D, Mash DC, (2007) MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding. Eur J Neurosci 26: 3229-3236.
29. Stone DM, Merchant KM, Hanson GR, Gibb JW, (1987) Immediate and long term effects of 3, 4-methylenedioxymethamphetamine on serotonin pathways in rat brain. Neuropharmacology 26: 1677-1683.
30. Thomasius R, Petersen K, Buchert R, Andresen B, Zapletalova P, Wartberg L, Nebeling B, Schmoldt A, (2003) Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users. Psychopharmacology 167: 85-96.